World's smallest glucose sensor approved by FDA
On May 31, Abbott announced its FreeStyle Libre 3 system is now FDA approved for diabetics ages 4 and up.
On May 31, healthcare giant Abbott announced its FreeStyle Libre 3 system is now “cleared by the U.S. Food and Drug Administration for people ages 4 and up in the U.S. living with diabetes.”
The continuous glucose monitor (CGM) system features a tiny sensor (see the header image) and this could enable diabetics to enjoy a better quality of life; especially for individuals with active lifestyles.
Here are some of the key specs:
1 minute between readings.
Sensor is smaller and thinner than 2 stacked U.S. pennies. It is currently the “world's smallest, thinnest glucose sensor” on the market.
Integrates with a smartphone app and cloud-based data system, “enabling caregivers and healthcare professionals to remotely monitor loved ones and patients as needed.”
User can wear one given sensor for 14 days.
In 2020, the system received CE mark in Europe.